Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

273,231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patients.
Tan Q, Wang D, Yang J, Xing P, Yang S, Li Y, Qin Y, He X, Liu Y, Zhou S, Duan H, Liang T, Wang H, Wang Y, Jiang S, Zhao F, Zhong Q, Zhou Y, Wang S, Dai J, Yao J, Wu D, Zhang Z, Sun Y, Han X, Yu X, Shi Y. Tan Q, et al. Among authors: wang h, wang y, wang d, wang s. Theranostics. 2020 May 16;10(14):6399-6410. doi: 10.7150/thno.45816. eCollection 2020. Theranostics. 2020. PMID: 32483460 Free PMC article.
Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy.
Tan Q, Dai L, Wang Y, Liu S, Liang T, Luo R, Wang S, Lou N, Chen H, Zhou Y, Zhong Q, Yang J, Xing P, Hu X, Liu Y, Zhou S, Yao J, Wu D, Zhang Z, Tang L, Yu X, Han X, Shi Y. Tan Q, et al. Among authors: wang y, wang s. Cancer Immunol Immunother. 2022 Jul;71(7):1681-1691. doi: 10.1007/s00262-021-03106-z. Epub 2021 Nov 24. Cancer Immunol Immunother. 2022. PMID: 34817638 Free PMC article.
273,231 results
You have reached the last available page of results. Please see the User Guide for more information.